ArticleTranslational oncology2023

Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape.

Danni Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.